)
Bruker (BRKR) investor relations material
Bruker Wolfe Research Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.State of the business and recent performance
Q3 revenue exceeded expectations, with strength in Life Science mass spectrometry and AXS divisions, and better-than-expected performance in defense and security systems, especially in Europe.
No significant pull-in from Q4; order timing and prudence led to a lower Q4 guide, with $40 million in semiconductor orders pushed to H1 2026.
Operating margin of 12.3% in Q3 was driven by favorable mix and improved profitability in LSMS, not by cost actions.
Book-to-bill ratio above one in Q3, with strong order demand from academic, government, and biopharma sectors, especially outside the U.S.
Sentiment in biopharma and industrial markets improved, with double-digit order growth in biopharma and stabilization in U.S. academic/government research.
Revenue and growth outlook for 2026
Entering 2026 with about seven months of backlog and $40 million in semiconductor revenue deferred from Q4 2025.
Academic/government research is 40-45% of sales, with notable strength in Japan, Korea, and Europe; U.S. outlook remains cautious but showed some Q3 improvement.
Organic revenue growth for 2026 expected to be flat to low single digits, with potential upside if market demand recovers.
Pricing actions are focused on neutralizing tariffs and leveraging innovative products, with global price adjustments of 3-6% expected to support revenue and margin.
Semiconductor business (~$300 million) is expected to grow, though order and revenue timing remains lumpy.
Margin expansion and cost actions
$120 million in cost savings targeted, representing nearly 10% of OPEX, with full run-rate expected in 2026.
Margin expansion of 300 basis points is targeted for 2026, with 60% from OPEX and 40% from COGS improvements.
Gross margin improvement will come from mix, price, and volume, with semiconductors and NMR as high-margin contributors.
M&A drag of $0.08 to EPS in 2025 will disappear in 2026, with integration synergies and cost controls in place.
OPEX expected to drop from $1.3 billion to about $1.2 billion in 2026, with no plans to scale back up post-acquisition.
Next Bruker earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage